Stock Price
51.50
Daily Change
-0.30 -0.58%
Monthly
2.69%
Yearly
0%
Q2 Forecast
50.16

Recordati reported EUR713.42M in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Almirall EUR 547.63M 12.83M Dec/2025
GlaxoSmithKline GBP 7.63B 991M Mar/2026
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Orion EUR 417.7M 277.6M Mar/2026
Sanofi EUR 11.24B 60M Mar/2026